Format

Send to

Choose Destination
J Pers Med. 2018 Dec 12;8(4). pii: E43. doi: 10.3390/jpm8040043.

The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018.

Author information

1
Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. sophie.visvikis-siest@inserm.fr.
2
Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. vesna.gorenjak@inserm.fr.
3
Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. maria.stathopoulou@inserm.fr.
4
Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. apetrelis@live.com.
5
Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. g.weryha@chru-nancy.fr.
6
Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. christine.masson@univ-lorraine.fr.
7
Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. brigitte.hiegel@univ-lorraine.fr.
8
Université de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. satish.kumar@univ-lorraine.fr.
9
INSERM UMR-S 1124, Université Paris Descartes, Université Sorbonne Paris Cité, 75270 Paris, France. robert.barouki@parisdescartes.fr.
10
Service de Biochimie Métabolomique et Protéomique, Hôpital Universitaire Necker Enfants Malades, AP-HP, 75015 Paris, France. robert.barouki@parisdescartes.fr.
11
Department of Epidemiology, Human Genetics and Environmental Sciences, UTHealth School of Public Health, Houston, TX 77030, USA. Eric.Boerwinkle@uth.tmc.edu.
12
Inserm UMR-S 1124, Paris-Descartes University, 75270 Paris, France. georges.dagher@inserm.fr.
13
Department of Clinical Pharmacology, Queen Mary University of London, London E1 4NS, UK. p.deloukas@qmul.ac.uk.
14
Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, NC 27599-2200, USA. innocent@email.unc.edu.
15
Randox Laboratories Ltd., Crumlin, County Antrim BT29 4XL, UK. john.lamont@randox.com.
16
PRAHealthSciences, 68165 Mannheim, Germany. marschlermichael@prahs.com.
17
Agena Bioscience GmbH, 22761 Hamburg, Germany. heiko.meyer@agenabio.com.
18
Biozentrum, University of Basel, 4056 Basel, Switzerland. urs-a.meyer@unibas.ch.
19
PharmGenetix Gmbh, 1090 Vienna, Austria. charity.nofziger@pharmgenetix.com.
20
Center for Health & Bioresources, Austrian Institute of Technology, 1210 Vienna, Austria. paulmichl@me.com.
21
NESMOS Department, University of Rome Sapienza, 00185 Rome, Italy. paulmichl@me.com.
22
Illumina, 81669 Munich, Germany. cvacher@illumina.com.
23
PRAHealthSciences, Salt Lake City, UT 84124, USA. WebsterLynn@prahs.com.

Abstract

The 9th traditional biannual conference on Systems Medicine, Personalised Health & Therapy-"The Odyssey from Hope to Practice", inspired by the Greek mythology, was a call to search for practical solutions in cardio-metabolic diseases and cancer, to resolve and overcome the obstacles in modern medicine by creating more interactions among disciplines, as well as between academic and industrial research, directed towards an effective 'roadmap' for personalised health and therapy. The 9th Santorini Conference, under the Presidency of Sofia Siest, the director of the INSERM U1122; IGE-PCV (www.u1122.inserm.fr), University of Lorraine, France, offered a rich and innovative scientific program. It gathered 34 worldwide distinguished speakers, who shared their passion for personalised medicine with 160 attendees in nine specific sessions on the following topics: First day: The Odyssey from hope to practice: Personalised medicine-landmarks and challenges Second day: Diseases to therapeutics-genotype to phenotype an "-OMICS" approach: focus on personalised therapy and precision medicine Third day: Gene-environment interactions and pharmacovigilance: a pharmacogenetics approach for deciphering disease "bench to clinic to reality" Fourth day: Pharmacogenomics to drug discovery: a big data approach and focus on clinical data and clinical practice. In this article we present the topics shared among the participants of the conference and we highlight the key messages.

KEYWORDS:

cancer; cardio-metabolic diseases; clinical trials; genetic screening; personalised medicine; pharmacogenomics; santorini conference; systems medicine; “-OMICs” biomarkers

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center